| 47 | Zevalin Radioimmunotherapy
Offers Safe And Effective Therapy For Relapsed Or Refractory,
B Cell Non-Hodgkin’s Lymphoma (NHL) Murray, James1; White, Christine2; Witzig, Thomas3; Gordon, Leo4; Wiseman, Gregory5; Emmanouilides, Christos6; Lister, John7; Multani, Pratik2 Hoag Cancer Center, Newport Beach, CA |
| 48 | Differences in occurrence
of natural T-cell responses against tumor associated antigens
between two adenocarcinomas: colorectal cancer and breast cancer Dirk Nagorsen, Ulrich Keilholz, Gerhard Schaller, Anne Letsch, Eckhard Thiel, and Carmen Scheibenbogen Department of Hematology, Oncology, and Transfusion Medicine, and Department of Gynecology, University Hospital Benjamin Franklin, Free University Berlin, Berlin, Germany |
| 49 | Regulation of Langerhans
cells by fever-range hyperthermia Ostberg JR, Patel R, Repasky EA Roswell Park Cancer Institute, Buffalo, NY |
| 50 | Phosphatidylinositol-3-
Kinase/Akt activity regulates c-FLIP expression in tumor cells Panka, David1; Mano, Toshiaki2; Suhara, Toshimitsu2; Walsh, Kenneth2; Mier, James1 1Hematology/Oncology, Beth Israel Deaconess Medical Center Boston, MA; 2St. Elizabeth Medical Center Boston, MA |
| 51 | The many faces of IFN-g in mammary
carcinoma immunity Beth A. Pulaski1, Mark Smyth2, and Suzanne Ostrand-Rosenberg1 1University of Maryland Baltimore County, Baltimore, MD; 2Peter MacCallum Cancer Institute, Australia |
| 52 | Interleukin-12 and
TCR BV gene usage in B-CLL, a role(s) for IL-12 therapeutic
intervention Rezvany MR, Jeddi-Tehrani M, Österborg A and Mellstedt H Immune and Genetherapy Lab, CCK, Dept. of Oncology and Center for Hematology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden |
| 53 | Role of L-Arginine
in the expression of the T cell receptor ζ chain in Jurkat
cells Paulo, C Rodriguez1; Faramarz, Taheri1; Zahra, Faghiri1; Arnold. H Zea1; Kirk, Culotta1; Juan, B Ochoa2; Augusto, C Ochoa1 1Tumor Immunology Program, Stanley S. Scott Cancer Center, and Department of Pediatrics, Louisisana State University Health ciences Center, New Orleans, LA; 2Department of Surgery, University of Kentucky Medical Center, Lexington, KY |
| 54 | Histamine Dihydrochloride protects
NK/T and NK lymphocytes against oxidatively induced apoptosis Ana Romero1, Svante Hermodsson1, Peter Naredi2, Kristoffer Hellstrand1 1Department of Virology, University of Goteborg, Goteborg, Sweden; 2Department of Surgery, University of Umea, Umea, Sweden |
| 55 | Transient synergistic induction
of apoptosis by the combination of TRAIL and Cisplatin in ovarian
cancer cells Rosaria R. S. Sassi, Adele M. Marrangoni, Robert P. Edwards and Anna E. Lokshin University of Pittsburgh, Pittsburgh, PA |
| 56 | Active specific immunotherapy
with tumor antigen-pulsed dendritic cells and activated T cells
that express CD40 ligand Takami Sato1, Mizue Terai1, Takekazu Aoyama1, Yuzo Fujii2, Sadamu Yamaguchi3, Tsutomu Arai2, Michael J. Mastrangelo1, David Berd1, and Kenichiro Hasumi2 1Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; 2Electro-Chemical & Cancer Institute, Chofu, Tokyo, Japan; 3Shuko-kai Clinic, Suginami, Tokyo, Japan |
| 57 | Immunogenicity of
tumor peptide vaccination is enhanced by GM-CSF in combination
with foreign helper protein Carmen Scheibenboger1, Dirk Schadendorf2, Michael H Foerster3, Dirk Nagorsen1, Udo Hofmann2, Nikolas Bechrakis3, Alexander Schmittel1, Armin Philipp2, Jan Siehl1, Eckhard Thiel1, Ulrich Keilholz1 1Universitätsklinikum Benjamin Franklin, Med. Klinik III und 2Augenklinik, Freie Universität, Berlin; 3Klinik für Dermatologie, Klinikum Mannheim, Universität Heidelberg, Mannheim, Germany |
| 58 | Generation of dendritic
cells from monocytes obtained by plastic adherence versus immunomagnetic
depletion of T and B cells P.M.Schiltz1, M. Loudovaris2, K.S. Spencer1, J.G. Bender2, R.O. Dillman1 1Hoag Cancer Center, CA; 2Nexell Therapeutics Inc., CA |
| 59 | Analysis of interleukin-10
secretion by melanoma cell lines derived from metastatic melanoma
patients P.M. Schiltz, K.S. Spencer, S.L. Hendry, S.M. Cilia, C.C. Malone, R.O. Dillman Hoag Cancer Center, Newport Beach, CA |
